Designing an evidence-informed package of essential health services for Universal Health Coverage: lessons learnt and challenges to implementation in Liberia.


Journal

BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275

Informations de publication

Date de publication:
25 Jun 2024
Historique:
received: 24 12 2023
accepted: 14 03 2024
medline: 27 6 2024
pubmed: 27 6 2024
entrez: 26 6 2024
Statut: epublish

Résumé

Liberia developed an evidence-informed package of health services for Universal Health Coverage (UHC) based on the Disease Control Priorities 3 evidence. This paper describes the policy decisions, methods and processes adopted for prioritisation, key features of the package and lessons learnt, with special emphasis on feasibility of implementation. Package design was led by the Ministry of Health. Prioritisation of essential services was based on evidence on disease burden, cost-effectiveness, financial risk, equity, budget impact, and feasibility of implementation. Fiscal space analysis was used to assess package affordability and options for expanding the budget envelope. The final adopted package focuses on primary healthcare and comprises a core subpackage of 78 publicly financed interventions and a complementary subpackage of 50 interventions funded through cost-sharing. The estimated per capita cost to the government is US$12.28, averting around 1.2 million DALYs. Key lessons learnt are described: (1) priority setting is essential for designing affordable packages of essential services; (2) the most realistic and affordable option when domestic resources are critically limited is to focus on basic, high-impact primary health services; (3) Liberia and many other countries will continue to rely on donor funding to expand the range of essential services until more domestic resources become available; (4) national leadership and effective engagement of key stakeholders are critical for a successful package design; (5) effective implementation is less likely unless the package cost is affordable and the health system gaps are assessed and addressed. A framework of action was employed to assess the consistency with the prerequisites for an appropriate package design. Based on the framework, Liberia developed a transparent and affordable package for UHC, but the challenges to implementation require further action by the government.

Identifiants

pubmed: 38925666
pii: bmjgh-2023-014904
doi: 10.1136/bmjgh-2023-014904
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Ala Alwan (A)

Disease Control Priorities 3 (DCP3) Country Translation Project, London School of Hygiene & Tropical Medicine, London, UK aalwan1@outlook.com.

Wilhemina Jallah (W)

Republic of Liberia Ministry of Health, Monrovia, Montserrado, Liberia.

Rob Baltussen (R)

Department for Health Evidence, Radboudumc, Nijmegen, The Netherlands.

Manuel Carballo (M)

International Centre for Migration, Health and Development, Geneva, Switzerland.

Ernest Gonyon (E)

Republic of Liberia Ministry of Health, Monrovia, Montserrado, Liberia.

Ina Gudumac (I)

Disease Control Priorities 3 (DCP3) Country Translation Project, London School of Hygiene & Tropical Medicine, London, UK.

Hassan Haghparast-Bidgoli (H)

Institute for Global Health, University College London, London, UK.

George Jacobs (G)

Republic of Liberia Ministry of Health, Monrovia, Montserrado, Liberia.

Gerard Joseph Abou Jaoude (GJ)

Institute for Global Health, University College London, London, UK.

Francis Nah Kateh (FN)

Republic of Liberia Ministry of Health, Monrovia, Montserrado, Liberia.

Gorbee Logan (G)

Republic of Liberia Ministry of Health, Monrovia, Montserrado, Liberia.

Jolene Skordis (J)

Institute for Global Health, University College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH